US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

49.38

-0.7100-1.42%

Post-market: 48.90-0.4800-0.97%19:10 EDT

Volume:2.19M

Turnover:106.06M

Market Cap:3.95B

PE:-13.06

High:50.10

Open:49.40

Low:45.57

Close:50.09

52wk High:58.40

52wk Low:21.34

Shares:79.99M

Float Shares:66.26M

Volume Ratio:2.13

T/O Rate:3.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.7801

EPS(LYR):-3.7544

ROE:-31.14%

ROA:-20.36%

PB:3.85

PE(LYR):-13.15

Loading ...

Overview Company News Filings

Akero Therapeutics’ efruxifermin shows efficacy in Phase 2b MASH, fibrosis trial

Akero Therapeutics Announces Promising Phase 2b HARMONY Trial Results Showing Efruxifermin Reduces Liver Fibrosis in Pre-cirrhotic MASH Patients

Akero Therapeutics Announces Lancet Publication of the Phase 2B Harmony Clinical Trial Demonstrating 96 Weeks Treatment With Efx Reduced Liver Fibrosis in Patients With Pre-Cirrhotic Mash

THOMSON REUTERS

Andrew Cheng, President and CEO, Reports Disposal of Akero Therapeutics Inc. Common Shares

Director Jane Henderson Reports Disposal of Common Shares in Akero Therapeutics Inc

Akero Therapeutics (AKRO) Receives a Buy from Canaccord Genuity

Akero Therapeutics Advances in MASH Treatment Development

Ritu Baral Recommends Buy Rating for Akero Therapeutics Amid Promising Clinical Trials and Strong Financial Position

Akero Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Akero Therapeutics Q2 Net Income USD -70.505 Million Vs. IBES Estimate USD -70.1 Million

Earnings Flash (AKRO) Akero Therapeutics Posts Q2 Net Loss $0.86 a Share, vs. FactSet Est of $0.96 Loss

MT Newswires Live

Akero Therapeutics Q2 EPS $(0.86) Beats $(0.93) Estimate

Akero Therapeutics Reports Increased Q2 2025 Operating Expenses, No Revenue or Profit Data Provided

Akero Therapeutics Q2 Basic EPS USD -0.86

THOMSON REUTERS

Akero Therapeutics Q2 Net Income USD -70.505 Million VS. Ibes Estimate USD -70.1 Million

THOMSON REUTERS

Chief Scientific Officer Timothy Rolph Reports Disposal of Akero Therapeutics Inc. Common Shares

Akero Therapeutics initiated with a Buy at TD Cowen

Akero Therapeutics Advances Efruxifermin Study for NASH Treatment

Akero Therapeutics Advances Phase 3 Study on Efruxifermin for NASH/MASH Cirrhosis

BB Biotech AG Reports Q2 2025 Net Loss of CHF 100 Million; USD Share Price Up 10.2%, Currency Drag Impacts CHF Performance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AKRO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AKRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKRO\",,,,,undefined,":{"symbol":"AKRO","market":"US","secType":"STK","nameCN":"Akero Therapeutics","latestPrice":49.38,"timestamp":1755288000000,"preClose":50.09,"halted":0,"volume":2185844,"hourTrading":{"tag":"盘后","latestPrice":48.9,"preClose":49.38,"latestTime":"19:10 EDT","volume":71923,"amount":3548201.062,"timestamp":1755299414687},"delay":0,"floatShares":66255947,"shares":79988975,"eps":-3.780149,"marketStatus":"Market Closed","change":-0.71,"latestTime":"08-15 16:00:00 EDT","open":49.4,"high":50.1,"low":45.57,"amount":106064665.811672,"amplitude":0.090437,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.780149,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1755504000000},"marketStatusCode":7,"adr":0,"listingDate":1561003200000,"exchange":"NASDAQ","adjPreClose":50.09,"preHourTrading":{"tag":"盘前","latestPrice":49.37,"preClose":50.09,"latestTime":"09:29 EDT","volume":4620,"amount":230603.8812,"timestamp":1755264599999},"postHourTrading":{"tag":"盘后","latestPrice":48.9,"preClose":49.38,"latestTime":"19:10 EDT","volume":71923,"amount":3548201.062,"timestamp":1755299414687},"volumeRatio":2.132173977695184,"impliedVol":0.6177,"impliedVolPercentile":0.468},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKRO\",,,,,undefined,":{"symbol":"AKRO","floatShares":66255947,"roa":"-20.36%","roe":"-31.14%","lyrEps":-3.754425,"volumeRatio":2.132173977695184,"shares":79988975,"dividePrice":0,"high":50.1,"amplitude":0.090437,"preClose":50.09,"low":45.57,"week52Low":21.34,"pbRate":"3.85","week52High":58.4,"institutionHeld":0,"latestPrice":49.38,"eps":-3.780149,"divideRate":0,"volume":2185844,"delay":0,"ttmEps":-3.780149,"open":49.4,"prevYearClose":27.82,"prevWeekClose":50.46,"prevMonthClose":48.85,"prevQuarterClose":53.36,"fiveDayClose":50.46,"twentyDayClose":52.08,"sixtyDayClose":47.57},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AKRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-08","symbol":"AKRO","fiscalQuarterEnding":"2025/06","expectedEps":-0.97,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"pre","actualEps":-0.86},{"market":"US","date":"2025-05-12","symbol":"AKRO","fiscalQuarterEnding":"2025/03","expectedEps":-1.01,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":0.9},{"market":"US","date":"2025-02-28","symbol":"AKRO","fiscalQuarterEnding":"2024/12","expectedEps":-1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":-0.99},{"market":"US","date":"2024-11-08","symbol":"AKRO","fiscalQuarterEnding":"2024/09","expectedEps":-0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":-1.05},{"market":"US","date":"2024-08-09","symbol":"AKRO","fiscalQuarterEnding":"2024/06","expectedEps":-0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-0.81}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AKRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AKRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3077,"buy":0.6923,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6923,"analysts":13,"updateTime":1754366400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AKRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AKRO","date":"2025-08-15","current":-14.109952,"percent":0.385909,"low":-28.138894,"twenty":-17.01274,"median":-11.309038,"eighty":-7.696826,"high":-2.507998,"avg":-12.303281,"sd":5.459751,"marketCap":4006647757},"quantilePoints":[{"date":"2020-08-21","current":-20.226207,"twenty":-14.199691,"median":-7.935084,"eighty":-6.483186,"marketCap":1198564561},{"date":"2020-08-28","current":-18.855931,"twenty":-14.270544,"median":-8.050767,"eighty":-6.503582,"marketCap":1117364761},{"date":"2020-09-04","current":-18.937913,"twenty":-14.36582,"median":-8.147976,"eighty":-6.526026,"marketCap":1122222869},{"date":"2020-09-11","current":-19.927557,"twenty":-14.422434,"median":-8.307937,"eighty":-6.575009,"marketCap":1180867169},{"date":"2020-09-18","current":-21.666753,"twenty":-14.622252,"median":-8.363107,"eighty":-6.57836,"marketCap":1283928453},{"date":"2020-09-25","current":-18.81494,"twenty":-15.118405,"median":-8.41206,"eighty":-6.580702,"marketCap":1114935707},{"date":"2020-10-02","current":-16.976194,"twenty":-16.976194,"median":-8.578813,"eighty":-6.611776,"marketCap":1005975293},{"date":"2020-10-09","current":-16.870788,"twenty":-17.0816,"median":-8.690351,"eighty":-6.611872,"marketCap":999729154},{"date":"2020-10-16","current":-16.601418,"twenty":-17.0816,"median":-8.720367,"eighty":-6.615223,"marketCap":983766801},{"date":"2020-10-23","current":-15.365827,"twenty":-16.976194,"median":-8.806893,"eighty":-6.645384,"marketCap":910548178},{"date":"2020-10-30","current":-15.547359,"twenty":-16.941059,"median":-8.939265,"eighty":-6.647202,"marketCap":921305416},{"date":"2020-11-06","current":-16.894211,"twenty":-16.941059,"median":-9.038124,"eighty":-6.668842,"marketCap":1001117185},{"date":"2020-11-13","current":-14.879191,"twenty":-16.976194,"median":-9.235843,"eighty":-6.682628,"marketCap":968739475},{"date":"2020-11-20","current":-15.428494,"twenty":-16.941059,"median":-9.436914,"eighty":-6.688949,"marketCap":1004502975},{"date":"2020-11-27","current":-15.588486,"twenty":-16.903581,"median":-9.520694,"eighty":-6.691622,"marketCap":1014919529},{"date":"2020-12-04","current":-15.204506,"twenty":-16.875473,"median":-9.616202,"eighty":-6.692298,"marketCap":989919800},{"date":"2020-12-11","current":-15.097846,"twenty":-16.852049,"median":-10.013317,"eighty":-6.694801,"marketCap":982975431},{"date":"2020-12-18","current":-13.593927,"twenty":-16.83331,"median":-10.683426,"eighty":-6.715821,"marketCap":885059829},{"date":"2020-12-24","current":-13.903244,"twenty":-16.815743,"median":-10.944954,"eighty":-6.749994,"marketCap":905198499},{"date":"2020-12-31","current":-13.759252,"twenty":-16.77358,"median":-11.062642,"eighty":-6.770718,"marketCap":895823601},{"date":"2021-01-08","current":-15.407162,"twenty":-16.675202,"median":-11.708067,"eighty":-6.783453,"marketCap":1003114102},{"date":"2021-01-15","current":-15.593819,"twenty":-16.56394,"median":-12.66777,"eighty":-6.808882,"marketCap":1015266747},{"date":"2021-01-22","current":-16.564432,"twenty":-16.55309,"median":-12.785067,"eighty":-6.826938,"marketCap":1078460505},{"date":"2021-01-29","current":-15.689813,"twenty":-16.548824,"median":-12.912954,"eighty":-6.843773,"marketCap":1021516679},{"date":"2021-02-05","current":-16.772421,"twenty":-16.548824,"median":-12.968433,"eighty":-6.849136,"marketCap":1092002025},{"date":"2021-02-12","current":-16.61243,"twenty":-16.701999,"median":-13.076409,"eighty":-6.867232,"marketCap":1081585471},{"date":"2021-02-19","current":-16.841751,"twenty":-16.756422,"median":-13.193949,"eighty":-6.896722,"marketCap":1096515865},{"date":"2021-02-26","current":-16.212452,"twenty":-16.724391,"median":-13.254083,"eighty":-6.912127,"marketCap":1055544088},{"date":"2021-03-05","current":-16.292447,"twenty":-16.724391,"median":-13.36191,"eighty":-6.921687,"marketCap":1060752364},{"date":"2021-03-12","current":-17.588377,"twenty":-16.829797,"median":-13.391272,"eighty":-6.937621,"marketCap":1145126448},{"date":"2021-03-19","current":-13.928847,"twenty":-16.829797,"median":-13.442548,"eighty":-6.940272,"marketCap":1103262221},{"date":"2021-03-26","current":-12.857735,"twenty":-16.806373,"median":-13.422189,"eighty":-6.953692,"marketCap":1018422643},{"date":"2021-04-01","current":-12.572398,"twenty":-16.779211,"median":-13.391272,"eighty":-6.986725,"marketCap":995821936},{"date":"2021-04-09","current":-12.186095,"twenty":-16.759622,"median":-13.36191,"eighty":-7.005181,"marketCap":965224055},{"date":"2021-04-16","current":-12.001724,"twenty":-16.730797,"median":-13.254083,"eighty":-7.010076,"marketCap":950620521},{"date":"2021-04-23","current":-12.712872,"twenty":-16.720151,"median":-13.193949,"eighty":-7.021386,"marketCap":1006948438},{"date":"2021-04-30","current":-13.540038,"twenty":-16.633762,"median":-13.251873,"eighty":-7.026294,"marketCap":1072465825},{"date":"2021-05-07","current":-12.014586,"twenty":-16.60362,"median":-13.236613,"eighty":-7.029401,"marketCap":951639318},{"date":"2021-05-14","current":-11.921269,"twenty":-16.571829,"median":-13.105079,"eighty":-7.033304,"marketCap":982443660},{"date":"2021-05-21","current":-11.376127,"twenty":-16.560166,"median":-13.053953,"eighty":-7.044844,"marketCap":937518019},{"date":"2021-05-28","current":-11.06341,"twenty":-16.517998,"median":-12.952173,"eighty":-7.052887,"marketCap":911746722},{"date":"2021-06-04","current":-11.333868,"twenty":-16.442554,"median":-12.927349,"eighty":-7.056239,"marketCap":934035411},{"date":"2021-06-11","current":-12.242437,"twenty":-16.386309,"median":-12.863037,"eighty":-7.062087,"marketCap":1008911479},{"date":"2021-06-18","current":-12.656575,"twenty":-16.339378,"median":-12.82894,"eighty":-7.068627,"marketCap":1043041036},{"date":"2021-06-25","current":-11.680392,"twenty":-16.310686,"median":-12.749498,"eighty":-7.072229,"marketCap":962592795},{"date":"2021-07-02","current":-10.446429,"twenty":-16.298918,"median":-12.723847,"eighty":-7.100785,"marketCap":860900648},{"date":"2021-07-09","current":-10.598561,"twenty":-16.260449,"median":-12.670345,"eighty":-7.129444,"marketCap":873438036},{"date":"2021-07-16","current":-9.436438,"twenty":-16.199652,"median":-12.638245,"eighty":-7.161301,"marketCap":777666321},{"date":"2021-07-23","current":-9.453342,"twenty":-16.168478,"median":-12.57922,"eighty":-7.187024,"marketCap":779059364},{"date":"2021-07-30","current":-9.060333,"twenty":-16.147558,"median":-12.479088,"eighty":-7.19254,"marketCap":746671112},{"date":"2021-08-06","current":-8.650421,"twenty":-16.123923,"median":-12.447136,"eighty":-7.202393,"marketCap":712889816},{"date":"2021-08-13","current":-6.907372,"twenty":-16.075119,"median":-12.414365,"eighty":-7.202393,"marketCap":657146683},{"date":"2021-08-20","current":-7.651243,"twenty":-16.028851,"median":-12.339604,"eighty":-7.202393,"marketCap":727916325},{"date":"2021-08-27","current":-8.431758,"twenty":-16.00233,"median":-12.242437,"eighty":-7.220693,"marketCap":802172157},{"date":"2021-09-03","current":-8.688265,"twenty":-15.99913,"median":-12.199253,"eighty":-7.26547,"marketCap":826575483},{"date":"2021-09-10","current":-9.171964,"twenty":-15.99913,"median":-12.102589,"eighty":-7.303321,"marketCap":872593181},{"date":"2021-09-17","current":-9.120663,"twenty":-15.987397,"median":-12.018464,"eighty":-7.305372,"marketCap":867712516},{"date":"2021-09-24","current":-8.695594,"twenty":-15.935133,"median":-11.995139,"eighty":-7.310459,"marketCap":827272720},{"date":"2021-10-01","current":-8.123949,"twenty":-15.911668,"median":-11.92972,"eighty":-7.311204,"marketCap":772888167},{"date":"2021-10-08","current":-7.739189,"twenty":-15.883512,"median":-11.872224,"eighty":-7.316577,"marketCap":736283180},{"date":"2021-10-15","current":-7.819805,"twenty":-15.801967,"median":-11.811395,"eighty":-7.327046,"marketCap":743952796},{"date":"2021-10-22","current":-7.775832,"twenty":-15.787905,"median":-11.732424,"eighty":-7.334694,"marketCap":739769369},{"date":"2021-10-29","current":-7.874771,"twenty":-15.770876,"median":-11.680392,"eighty":-7.355909,"marketCap":749182080},{"date":"2021-11-05","current":-9.615355,"twenty":-15.731411,"median":-11.556183,"eighty":-7.359781,"marketCap":914776072},{"date":"2021-11-12","current":-9.011673,"twenty":-15.722879,"median":-11.376127,"eighty":-7.364919,"marketCap":883720689},{"date":"2021-11-19","current":-8.833788,"twenty":-15.702613,"median":-11.283252,"eighty":-7.376232,"marketCap":866276538},{"date":"2021-11-26","current":-7.517436,"twenty":-15.689813,"median":-11.181736,"eighty":-7.377397,"marketCap":737189821},{"date":"2021-12-03","current":-7.079838,"twenty":-15.68448,"median":-11.131025,"eighty":-7.362163,"marketCap":694277209},{"date":"2021-12-10","current":-7.072722,"twenty":-15.600062,"median":-11.076102,"eighty":-7.35509,"marketCap":693579443},{"date":"2021-12-17","current":-7.513878,"twenty":-15.593819,"median":-10.951492,"eighty":-7.326409,"marketCap":736840938},{"date":"2021-12-23","current":-7.809168,"twenty":-15.589553,"median":-10.907052,"eighty":-7.328958,"marketCap":765798228},{"date":"2021-12-31","current":-7.524551,"twenty":-15.555584,"median":-10.8249,"eighty":-7.349991,"marketCap":737887587},{"date":"2022-01-07","current":-7.094069,"twenty":-15.529063,"median":-10.598561,"eighty":-7.323951,"marketCap":695672741},{"date":"2022-01-14","current":-7.919457,"twenty":-15.524489,"median":-10.497139,"eighty":-7.31339,"marketCap":776613602},{"date":"2022-01-21","current":-7.090511,"twenty":-15.520644,"median":-10.431639,"eighty":-7.303711,"marketCap":695323858},{"date":"2022-01-28","current":-5.873775,"twenty":-15.486728,"median":-10.188649,"eighty":-7.264127,"marketCap":576005866},{"date":"2022-02-04","current":-6.332719,"twenty":-15.443427,"median":-10.07455,"eighty":-7.206289,"marketCap":621011775},{"date":"2022-02-11","current":-6.585316,"twenty":-15.415695,"median":-9.939321,"eighty":-7.186417,"marketCap":645782470},{"date":"2022-02-18","current":-6.311373,"twenty":-15.394363,"median":-9.66909,"eighty":-7.140107,"marketCap":618918477},{"date":"2022-02-25","current":-6.253737,"twenty":-15.38583,"median":-9.608238,"eighty":-7.1083,"marketCap":630232830},{"date":"2022-03-04","current":-5.301779,"twenty":-15.38583,"median":-9.546312,"eighty":-7.077703,"marketCap":534297388},{"date":"2022-03-11","current":-4.936978,"twenty":-15.382514,"median":-9.469024,"eighty":-7.069892,"marketCap":497533806},{"date":"2022-03-18","current":-5.121116,"twenty":-15.377539,"median":-9.443129,"eighty":-7.055568,"marketCap":516090661},{"date":"2022-03-25","current":-4.971721,"twenty":-15.372854,"median":-9.419629,"eighty":-7.028126,"marketCap":501035099},{"date":"2022-04-01","current":-5.17323,"twenty":-15.363485,"median":-9.339243,"eighty":-7.008112,"marketCap":521342602},{"date":"2022-04-08","current":-4.818852,"twenty":-15.355382,"median":-9.307822,"eighty":-6.94564,"marketCap":485629408},{"date":"2022-04-14","current":-4.28381,"twenty":-15.348499,"median":-9.246189,"eighty":-6.914039,"marketCap":431709488},{"date":"2022-04-22","current":-3.543784,"twenty":-15.346366,"median":-9.225135,"eighty":-6.867232,"marketCap":357131937},{"date":"2022-04-29","current":-3.64558,"twenty":-15.3325,"median":-9.206127,"eighty":-6.806449,"marketCap":367390588},{"date":"2022-05-06","current":-3.498657,"twenty":-15.301129,"median":-9.171964,"eighty":-6.770047,"marketCap":390855954},{"date":"2022-05-13","current":-2.943762,"twenty":-15.260978,"median":-9.104173,"eighty":-6.692925,"marketCap":328865359},{"date":"2022-05-20","current":-2.812093,"twenty":-15.249684,"median":-9.060333,"eighty":-6.685735,"marketCap":314155726},{"date":"2022-05-27","current":-2.771338,"twenty":-15.202373,"median":-9.033589,"eighty":-6.645748,"marketCap":309602745},{"date":"2022-06-03","current":-2.636533,"twenty":-15.19384,"median":-9.016208,"eighty":-6.611776,"marketCap":294542883},{"date":"2022-06-10","current":-2.677288,"twenty":-15.119178,"median":-8.977752,"eighty":-6.575009,"marketCap":299095864},{"date":"2022-06-17","current":-3.812157,"twenty":-15.118405,"median":-8.904459,"eighty":-6.496374,"marketCap":425878889},{"date":"2022-06-24","current":-3.257262,"twenty":-15.1149,"median":-8.876052,"eighty":-6.461681,"marketCap":363888294},{"date":"2022-07-01","current":-3.182022,"twenty":-15.109614,"median":-8.838505,"eighty":-6.428909,"marketCap":355482790},{"date":"2022-07-08","current":-3.583302,"twenty":-15.108306,"median":-8.833788,"eighty":-6.408616,"marketCap":400312147},{"date":"2022-07-15","current":-3.461037,"twenty":-15.105175,"median":-8.808041,"eighty":-6.393968,"marketCap":386653202},{"date":"2022-07-22","current":-3.388932,"twenty":-15.099979,"median":-8.787204,"eighty":-6.362726,"marketCap":378597927},{"date":"2022-07-29","current":-3.210237,"twenty":-15.097846,"median":-8.743696,"eighty":-6.329033,"marketCap":358634854},{"date":"2022-08-05","current":-4.69873,"twenty":-15.097846,"median":-8.71306,"eighty":-6.313508,"marketCap":517734250},{"date":"2022-08-12","current":-4.535059,"twenty":-15.044382,"median":-8.694273,"eighty":-6.274771,"marketCap":499699965},{"date":"2022-08-19","current":-4.105421,"twenty":-14.963008,"median":-8.688265,"eighty":-6.239603,"marketCap":452359969},{"date":"2022-08-26","current":-4.054274,"twenty":-14.926121,"median":-8.634099,"eighty":-6.193714,"marketCap":446724255},{"date":"2022-09-02","current":-4.32024,"twenty":-14.912256,"median":-8.59971,"eighty":-6.178935,"marketCap":476029967},{"date":"2022-09-09","current":-3.992897,"twenty":-14.90191,"median":-8.578813,"eighty":-6.162895,"marketCap":439961398},{"date":"2022-09-16","current":-10.688857,"twenty":-14.889272,"median":-8.589261,"eighty":-6.162895,"marketCap":1177762358},{"date":"2022-09-23","current":-10.914994,"twenty":-14.870658,"median":-8.620242,"eighty":-6.168247,"marketCap":1202679497},{"date":"2022-09-30","current":-14.344096,"twenty":-14.841176,"median":-8.669343,"eighty":-6.172565,"marketCap":1580518599},{"date":"2022-10-07","current":-16.06286,"twenty":-14.90191,"median":-8.692953,"eighty":-6.178291,"marketCap":1769902325},{"date":"2022-10-14","current":-16.218729,"twenty":-15.062203,"median":-8.706159,"eighty":-6.181075,"marketCap":1787076830},{"date":"2022-10-21","current":-17.899579,"twenty":-15.106172,"median":-8.733167,"eighty":-6.182581,"marketCap":1972282974},{"date":"2022-10-28","current":-17.191852,"twenty":-15.118869,"median":-8.777975,"eighty":-6.184494,"marketCap":1894301439},{"date":"2022-11-04","current":-14.82271,"twenty":-15.238389,"median":-8.806893,"eighty":-6.191427,"marketCap":1799447397},{"date":"2022-11-11","current":-15.654754,"twenty":-15.241294,"median":-8.830394,"eighty":-6.202112,"marketCap":1900455879},{"date":"2022-11-18","current":-17.018382,"twenty":-15.344233,"median":-8.838505,"eighty":-6.217951,"marketCap":2065997557},{"date":"2022-11-25","current":-17.657823,"twenty":-15.364656,"median":-8.871485,"eighty":-6.233151,"marketCap":2143624446},{"date":"2022-12-02","current":-17.511445,"twenty":-15.38583,"median":-8.904459,"eighty":-6.23543,"marketCap":2125854435},{"date":"2022-12-09","current":-16.544579,"twenty":-15.45836,"median":-8.977752,"eighty":-6.245769,"marketCap":2008478838},{"date":"2022-12-16","current":-18.085402,"twenty":-15.542785,"median":-9.016208,"eighty":-6.25566,"marketCap":2195531582},{"date":"2022-12-23","current":-18.817292,"twenty":-15.598813,"median":-9.038124,"eighty":-6.265634,"marketCap":2284381636},{"date":"2022-12-30","current":-21.109265,"twenty":-15.689813,"median":-9.060333,"eighty":-6.274771,"marketCap":2562622592},{"date":"2023-01-06","current":-17.264914,"twenty":-15.742077,"median":-9.087684,"eighty":-6.274771,"marketCap":2095925996},{"date":"2023-01-13","current":-19.352728,"twenty":-15.90285,"median":-9.158407,"eighty":-6.274771,"marketCap":2349382464},{"date":"2023-01-20","current":-18.486015,"twenty":-15.963932,"median":-9.185876,"eighty":-6.286244,"marketCap":2244165296},{"date":"2023-01-27","current":-18.971374,"twenty":-16.002649,"median":-9.222439,"eighty":-6.304381,"marketCap":2303086910},{"date":"2023-02-03","current":-18.474459,"twenty":-16.075766,"median":-9.235843,"eighty":-6.313508,"marketCap":2242762400},{"date":"2023-02-10","current":-17.045347,"twenty":-16.146079,"median":-9.286111,"eighty":-6.317604,"marketCap":2069270980},{"date":"2023-02-17","current":-17.330399,"twenty":-16.214963,"median":-9.33713,"eighty":-6.321298,"marketCap":2103875738},{"date":"2023-02-24","current":-16.113149,"twenty":-16.271575,"median":-9.402821,"eighty":-6.324353,"marketCap":1956104070},{"date":"2023-03-03","current":-18.328081,"twenty":-16.390575,"median":-9.436914,"eighty":-6.328362,"marketCap":2224992389},{"date":"2023-03-10","current":-15.92825,"twenty":-16.526424,"median":-9.449269,"eighty":-6.331311,"marketCap":1933657741},{"date":"2023-03-17","current":-16.866842,"twenty":-16.526424,"median":-9.48048,"eighty":-6.341408,"marketCap":1889642887},{"date":"2023-03-24","current":-15.701298,"twenty":-16.526424,"median":-9.55361,"eighty":-6.35699,"marketCap":1759063538},{"date":"2023-03-31","current":-16.040899,"twenty":-16.526424,"median":-9.615355,"eighty":-6.362089,"marketCap":1797110039},{"date":"2023-04-06","current":-15.466512,"twenty":-16.503004,"median":-9.706896,"eighty":-6.364648,"marketCap":1732759784},{"date":"2023-04-14","current":-15.948662,"twenty":-16.467122,"median":-9.922422,"eighty":-6.369917,"marketCap":1786776421},{"date":"2023-04-21","current":-17.914993,"twenty":-16.543441,"median":-10.07455,"eighty":-6.38178,"marketCap":2007070359},{"date":"2023-04-28","current":-18.292327,"twenty":-16.600066,"median":-10.178084,"eighty":-6.388881,"marketCap":2049344250},{"date":"2023-05-05","current":-19.341759,"twenty":-16.723331,"median":-10.416848,"eighty":-6.399732,"marketCap":2166915288},{"date":"2023-05-12","current":-19.709144,"twenty":-16.793458,"median":-10.497139,"eighty":-6.403676,"marketCap":2208074572},{"date":"2023-05-19","current":-21.880003,"twenty":-16.846241,"median":-10.598561,"eighty":-6.408616,"marketCap":2446950172},{"date":"2023-05-26","current":-21.673083,"twenty":-16.877694,"median":-10.76971,"eighty":-6.408616,"marketCap":2423809191},{"date":"2023-06-02","current":-22.321148,"twenty":-16.89619,"median":-10.850255,"eighty":-6.408616,"marketCap":2496285567},{"date":"2023-06-09","current":-25.556527,"twenty":-16.941059,"median":-10.907052,"eighty":-6.418104,"marketCap":2858114193},{"date":"2023-06-16","current":-27.312734,"twenty":-16.969744,"median":-10.944954,"eighty":-6.420855,"marketCap":3054519640},{"date":"2023-06-23","current":-25.729674,"twenty":-16.984484,"median":-11.032612,"eighty":-6.428909,"marketCap":2877478110},{"date":"2023-06-30","current":-22.083689,"twenty":-17.029168,"median":-11.065029,"eighty":-6.43177,"marketCap":2469729337},{"date":"2023-07-07","current":-22.276624,"twenty":-17.057464,"median":-11.105684,"eighty":-6.438144,"marketCap":2491306274},{"date":"2023-07-14","current":-22.425036,"twenty":-17.087456,"median":-11.138265,"eighty":-6.45101,"marketCap":2507903917},{"date":"2023-07-21","current":-21.866018,"twenty":-17.119501,"median":-11.178937,"eighty":-6.45946,"marketCap":2445386127},{"date":"2023-07-28","current":-20.376952,"twenty":-17.14627,"median":-11.22673,"eighty":-6.46789,"marketCap":2278856438},{"date":"2023-08-04","current":-21.772024,"twenty":-17.217199,"median":-11.335981,"eighty":-6.476813,"marketCap":2434874286},{"date":"2023-08-11","current":-22.068848,"twenty":-17.249506,"median":-11.376127,"eighty":-6.485785,"marketCap":2468069573},{"date":"2023-08-18","current":-21.775894,"twenty":-17.26265,"median":-11.556183,"eighty":-6.498237,"marketCap":2515442397},{"date":"2023-08-25","current":-22.579734,"twenty":-17.33271,"median":-11.680392,"eighty":-6.506131,"marketCap":2608298029},{"date":"2023-09-01","current":-23.888984,"twenty":-17.483375,"median":-11.732424,"eighty":-6.522472,"marketCap":2759535945},{"date":"2023-09-08","current":-23.975625,"twenty":-17.503637,"median":-11.779701,"eighty":-6.543409,"marketCap":2769544336},{"date":"2023-09-15","current":-24.423273,"twenty":-17.583044,"median":-11.85686,"eighty":-6.575679,"marketCap":2821254359},{"date":"2023-09-22","current":-23.325814,"twenty":-17.65422,"median":-11.925494,"eighty":-6.578828,"marketCap":2694481400},{"date":"2023-09-29","current":-23.200665,"twenty":-17.772652,"median":-11.988554,"eighty":-6.581625,"marketCap":2680024835},{"date":"2023-10-06","current":-22.825219,"twenty":-17.880201,"median":-12.016525,"eighty":-6.590608,"marketCap":2636655138},{"date":"2023-10-13","current":-7.070908,"twenty":-17.909563,"median":-12.014586,"eighty":-6.611795,"marketCap":816795950},{"date":"2023-10-20","current":-5.992703,"twenty":-17.880201,"median":-11.976041,"eighty":-6.609411,"marketCap":692247078},{"date":"2023-10-27","current":-5.63651,"twenty":-17.841444,"median":-11.946624,"eighty":-6.58347,"marketCap":651101469},{"date":"2023-11-03","current":-6.41147,"twenty":-17.798894,"median":-11.887589,"eighty":-6.526817,"marketCap":740620971},{"date":"2023-11-10","current":-6.77729,"twenty":-17.789965,"median":-11.82287,"eighty":-6.559209,"marketCap":782878624},{"date":"2023-11-17","current":-6.724365,"twenty":-17.782933,"median":-11.746423,"eighty":-6.57702,"marketCap":804449266},{"date":"2023-11-24","current":-7.60915,"twenty":-17.764215,"median":-11.708067,"eighty":-6.579297,"marketCap":910297854},{"date":"2023-12-01","current":-7.795421,"twenty":-17.712824,"median":-11.593015,"eighty":-6.582548,"marketCap":932581767},{"date":"2023-12-08","current":-9.20642,"twenty":-17.667352,"median":-11.477549,"eighty":-6.594718,"marketCap":1101382409},{"date":"2023-12-15","current":-10.393894,"twenty":-17.656792,"median":-11.345602,"eighty":-6.610002,"marketCap":1243442356},{"date":"2023-12-22","current":-10.393894,"twenty":-17.653195,"median":-11.232635,"eighty":-6.611814,"marketCap":1243442356},{"date":"2023-12-29","current":-11.185544,"twenty":-17.650119,"median":-11.210572,"eighty":-6.611872,"marketCap":1338148987},{"date":"2024-01-05","current":-10.631389,"twenty":-17.631629,"median":-11.188816,"eighty":-6.612311,"marketCap":1271854345},{"date":"2024-01-12","current":-10.51497,"twenty":-17.607747,"median":-11.177301,"eighty":-6.614175,"marketCap":1257926900},{"date":"2024-01-19","current":-10.044637,"twenty":-17.595377,"median":-11.143097,"eighty":-6.627287,"marketCap":1201660019},{"date":"2024-01-26","current":-10.272818,"twenty":-17.577711,"median":-11.122573,"eighty":-6.646111,"marketCap":1228957812},{"date":"2024-02-02","current":-9.769888,"twenty":-17.54931,"median":-11.065029,"eighty":-6.655858,"marketCap":1168791247},{"date":"2024-02-09","current":-8.661579,"twenty":-17.523002,"median":-11.036489,"eighty":-6.674356,"marketCap":1036201963},{"date":"2024-02-16","current":-9.970129,"twenty":-17.508363,"median":-10.963741,"eighty":-6.68355,"marketCap":1192746454},{"date":"2024-02-23","current":-11.274022,"twenty":-17.503637,"median":-10.963741,"eighty":-6.685735,"marketCap":1348733846},{"date":"2024-03-01","current":-9.907861,"twenty":-17.499475,"median":-10.97599,"eighty":-6.689569,"marketCap":1503607043},{"date":"2024-03-08","current":-13.693736,"twenty":-17.484481,"median":-11.032612,"eighty":-6.692096,"marketCap":2078147664},{"date":"2024-03-15","current":-12.434807,"twenty":-17.483928,"median":-11.06341,"eighty":-6.692292,"marketCap":1887093841},{"date":"2024-03-22","current":-11.785126,"twenty":-17.46609,"median":-11.105684,"eighty":-6.692925,"marketCap":1788498876},{"date":"2024-03-28","current":-11.108185,"twenty":-17.403588,"median":-11.09849,"eighty":-6.695426,"marketCap":1685767059},{"date":"2024-04-05","current":-10.435788,"twenty":-17.38818,"median":-11.080926,"eighty":-6.72092,"marketCap":1583724718},{"date":"2024-04-12","current":-9.922403,"twenty":-17.334251,"median":-11.054626,"eighty":-6.724067,"marketCap":1505814011},{"date":"2024-04-19","current":-9.345654,"twenty":-17.330399,"median":-11.028735,"eighty":-6.724365,"marketCap":1418287153},{"date":"2024-04-26","current":-8.625706,"twenty":-17.291878,"median":-10.963741,"eighty":-6.769377,"marketCap":1309028562},{"date":"2024-05-03","current":-8.981124,"twenty":-17.284393,"median":-10.935543,"eighty":-6.772729,"marketCap":1362966347},{"date":"2024-05-10","current":-9.477797,"twenty":-17.264914,"median":-10.911023,"eighty":-6.77729,"marketCap":1438340945},{"date":"2024-05-17","current":-7.996231,"twenty":-17.259255,"median":-10.873245,"eighty":-6.784548,"marketCap":1433500375},{"date":"2024-05-24","current":-7.294198,"twenty":-17.259255,"median":-10.8249,"eighty":-6.799538,"marketCap":1307645542},{"date":"2024-05-31","current":-7.259483,"twenty":-17.255885,"median":-10.76904,"eighty":-6.801777,"marketCap":1301421951},{"date":"2024-06-07","current":-8.879558,"twenty":-17.250613,"median":-10.740823,"eighty":-6.813105,"marketCap":1591856181},{"date":"2024-06-14","current":-9.249861,"twenty":-17.249506,"median":-10.67875,"eighty":-6.820885,"marketCap":1658241147},{"date":"2024-06-21","current":-8.94899,"twenty":-17.247965,"median":-10.636046,"eighty":-6.830979,"marketCap":1604303362},{"date":"2024-06-28","current":-9.049281,"twenty":-17.247965,"median":-10.636046,"eighty":-6.902975,"marketCap":1622282624},{"date":"2024-07-05","current":-8.273959,"twenty":-17.247965,"median":-10.636046,"eighty":-6.928064,"marketCap":1483289100},{"date":"2024-07-12","current":-9.905606,"twenty":-17.247965,"median":-10.636046,"eighty":-6.96715,"marketCap":1775797859},{"date":"2024-07-19","current":-10.322197,"twenty":-17.247965,"median":-10.668643,"eighty":-7.013582,"marketCap":1850480947},{"date":"2024-07-26","current":-10.846793,"twenty":-17.247965,"median":-10.716887,"eighty":-7.020403,"marketCap":1944526316},{"date":"2024-08-02","current":-9.708883,"twenty":-17.247965,"median":-10.716887,"eighty":-7.020403,"marketCap":1740530846},{"date":"2024-08-09","current":-8.412922,"twenty":-17.247965,"median":-10.716887,"eighty":-7.020403,"marketCap":1717716853},{"date":"2024-08-16","current":-8.453729,"twenty":-17.247965,"median":-10.716887,"eighty":-7.020403,"marketCap":1726048544},{"date":"2024-08-23","current":-9.337868,"twenty":-17.247965,"median":-10.716887,"eighty":-7.020403,"marketCap":1906568504},{"date":"2024-08-30","current":-9.249454,"twenty":-17.247965,"median":-10.716887,"eighty":-7.020403,"marketCap":1888516508},{"date":"2024-09-06","current":-8.980812,"twenty":-17.247965,"median":-10.716887,"eighty":-7.020403,"marketCap":1833666213},{"date":"2024-09-13","current":-9.297061,"twenty":-17.247965,"median":-10.716887,"eighty":-7.020403,"marketCap":1898236814},{"date":"2024-09-20","current":-9.548701,"twenty":-17.247965,"median":-10.716887,"eighty":-7.037283,"marketCap":1949615572},{"date":"2024-09-27","current":-9.60311,"twenty":-17.247965,"median":-10.716887,"eighty":-7.063693,"marketCap":1960724492},{"date":"2024-10-04","current":-9.60311,"twenty":-17.247965,"median":-10.716887,"eighty":-7.069165,"marketCap":1960724492},{"date":"2024-10-11","current":-10.075784,"twenty":-17.247965,"median":-10.716887,"eighty":-7.077703,"marketCap":2057233241},{"date":"2024-10-18","current":-10.619869,"twenty":-17.247965,"median":-10.716887,"eighty":-7.119091,"marketCap":2168322447},{"date":"2024-10-25","current":-9.973768,"twenty":-17.247965,"median":-10.716887,"eighty":-7.186342,"marketCap":2036404014},{"date":"2024-11-01","current":-10.993928,"twenty":-17.247965,"median":-10.740823,"eighty":-7.198234,"marketCap":2244696276},{"date":"2024-11-08","current":-10.136415,"twenty":-17.247965,"median":-10.789896,"eighty":-7.239773,"marketCap":2404580648},{"date":"2024-11-15","current":-8.265077,"twenty":-17.247965,"median":-10.789896,"eighty":-7.263048,"marketCap":1960658067},{"date":"2024-11-22","current":-9.63033,"twenty":-17.247965,"median":-10.789896,"eighty":-7.3015,"marketCap":2284526114},{"date":"2024-11-29","current":-9.444961,"twenty":-17.247965,"median":-10.789896,"eighty":-7.311933,"marketCap":2240552650},{"date":"2024-12-06","current":-9.153668,"twenty":-17.247965,"median":-10.789896,"eighty":-7.377912,"marketCap":2171451494},{"date":"2024-12-13","current":-8.500465,"twenty":-17.247965,"median":-10.789896,"eighty":-7.419619,"marketCap":2016497385},{"date":"2024-12-20","current":-8.632871,"twenty":-17.247965,"median":-10.789896,"eighty":-7.49118,"marketCap":2047907002},{"date":"2024-12-27","current":-8.312155,"twenty":-17.247965,"median":-10.789896,"eighty":-7.515301,"marketCap":1971825931},{"date":"2025-01-03","current":-8.309212,"twenty":-17.247965,"median":-10.789896,"eighty":-7.522889,"marketCap":1971127939},{"date":"2025-01-10","current":-7.308811,"twenty":-17.248735,"median":-10.806215,"eighty":-7.541835,"marketCap":1733810836},{"date":"2025-01-17","current":-7.397082,"twenty":-17.248735,"median":-10.806215,"eighty":-7.541835,"marketCap":1754750580},{"date":"2025-01-24","current":-7.703087,"twenty":-17.248735,"median":-10.806215,"eighty":-7.55012,"marketCap":1827341694},{"date":"2025-01-31","current":-17.377475,"twenty":-17.253935,"median":-10.885804,"eighty":-7.565109,"marketCap":4122319277},{"date":"2025-02-07","current":-17.419247,"twenty":-17.290381,"median":-10.929009,"eighty":-7.565109,"marketCap":4132228698},{"date":"2025-02-14","current":-16.233543,"twenty":-17.290381,"median":-10.978483,"eighty":-7.565109,"marketCap":3850953585},{"date":"2025-02-21","current":-16.657698,"twenty":-17.290381,"median":-11.041165,"eighty":-7.581894,"marketCap":3951572325},{"date":"2025-02-28","current":-15.515912,"twenty":-17.290381,"median":-11.09849,"eighty":-7.611442,"marketCap":3910940687},{"date":"2025-03-07","current":-13.304768,"twenty":-17.291878,"median":-11.138265,"eighty":-7.67323,"marketCap":3353599791},{"date":"2025-03-14","current":-13.946,"twenty":-17.291878,"median":-11.194413,"eighty":-7.697202,"marketCap":3515228651},{"date":"2025-03-21","current":-14.283989,"twenty":-17.291878,"median":-11.274022,"eighty":-7.697202,"marketCap":3600422188},{"date":"2025-03-28","current":-13.494294,"twenty":-17.291878,"median":-11.417124,"eighty":-7.697202,"marketCap":3401371868},{"date":"2025-04-04","current":-11.602187,"twenty":-17.291878,"median":-11.444384,"eighty":-7.697202,"marketCap":2924447301},{"date":"2025-04-11","current":-11.265777,"twenty":-17.290381,"median":-11.357615,"eighty":-7.697202,"marketCap":2839651865},{"date":"2025-04-17","current":-11.886477,"twenty":-17.290381,"median":-11.357615,"eighty":-7.697202,"marketCap":2996105416},{"date":"2025-04-25","current":-12.950985,"twenty":-17.291878,"median":-11.35311,"eighty":-7.697202,"marketCap":3264425248},{"date":"2025-05-02","current":-14.183951,"twenty":-17.291878,"median":-11.35311,"eighty":-7.697202,"marketCap":3575206691},{"date":"2025-05-09","current":-12.597068,"twenty":-17.291878,"median":-11.35311,"eighty":-7.697202,"marketCap":3175216996},{"date":"2025-05-16","current":-11.500187,"twenty":-17.291878,"median":-11.338094,"eighty":-7.697202,"marketCap":3098621945},{"date":"2025-05-23","current":-14.488402,"twenty":-17.291878,"median":-11.333868,"eighty":-7.697202,"marketCap":3903769402},{"date":"2025-05-30","current":-14.210291,"twenty":-17.291878,"median":-11.333868,"eighty":-7.697202,"marketCap":3828834887},{"date":"2025-06-06","current":-15.95884,"twenty":-17.291878,"median":-11.333868,"eighty":-7.697202,"marketCap":4299965725},{"date":"2025-06-13","current":-15.846412,"twenty":-17.291878,"median":-11.333868,"eighty":-7.697202,"marketCap":4269673049},{"date":"2025-06-20","current":-16.242868,"twenty":-17.294216,"median":-11.309038,"eighty":-7.696826,"marketCap":4376494593},{"date":"2025-06-27","current":-16.651159,"twenty":-17.294216,"median":-11.309038,"eighty":-7.696826,"marketCap":4486504839},{"date":"2025-07-03","current":-15.316817,"twenty":-17.26881,"median":-11.309038,"eighty":-7.696826,"marketCap":4126978598},{"date":"2025-07-11","current":-15.384866,"twenty":-17.249506,"median":-11.309038,"eighty":-7.696826,"marketCap":4145313640},{"date":"2025-07-18","current":-16.074226,"twenty":-17.182505,"median":-11.309038,"eighty":-7.696826,"marketCap":4331055578},{"date":"2025-07-25","current":-14.94403,"twenty":-17.131633,"median":-11.309038,"eighty":-7.696826,"marketCap":4026534460},{"date":"2025-08-01","current":-14.452898,"twenty":-17.093815,"median":-11.309038,"eighty":-7.696826,"marketCap":3894203294},{"date":"2025-08-08","current":-14.926279,"twenty":-17.062017,"median":-11.309038,"eighty":-7.696826,"marketCap":4021751406},{"date":"2025-08-15","current":-14.109952,"twenty":-17.01274,"median":-11.309038,"eighty":-7.696826,"marketCap":4006647757}],"updateTime":1755359504432},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AKRO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559603599","title":"Akero Therapeutics’ efruxifermin shows efficacy in Phase 2b MASH, fibrosis trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2559603599","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559603599?lang=en_us&edition=fundamental","pubTime":"2025-08-15 06:35","pubTimestamp":1755210913,"startTime":"0","endTime":"0","summary":"Akero Therapeutics (AKRO) announced publication of 96-week final results from the Phase 2b HARMONY trial in The Lancet in adults with biopsy-confir...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/akero-therapeutics-efruxifermin-shows-efficacy-in-phase-2b-mash-fibrosis-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/akero-therapeutics-efruxifermin-shows-efficacy-in-phase-2b-mash-fibrosis-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKRO","BK4139","BK4588","BK4585","BK4505"],"gpt_icon":0},{"id":"2559296702","title":"Akero Therapeutics Announces Promising Phase 2b HARMONY Trial Results Showing Efruxifermin Reduces Liver Fibrosis in Pre-cirrhotic MASH Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2559296702","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559296702?lang=en_us&edition=fundamental","pubTime":"2025-08-15 06:30","pubTimestamp":1755210613,"startTime":"0","endTime":"0","summary":"Akero Therapeutics Announces Promising Phase 2b HARMONY Trial Results Showing Efruxifermin Reduces Liver Fibrosis in Pre-cirrhotic MASH Patients. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akero Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on August 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL46Ddqs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BKPKM429.USD","AKRO","BK4505","LU2210150020.SGD","LU0314104364.USD","LU2210149790.SGD","BK4588","LU2095319765.USD","BK4112","BK4585","IE00BGHQF748.EUR","BK4139","NDAQ"],"gpt_icon":0},{"id":"2559043967","title":"Akero Therapeutics Announces Lancet Publication of the Phase 2B Harmony Clinical Trial Demonstrating 96 Weeks Treatment With Efx Reduced Liver Fibrosis in Patients With Pre-Cirrhotic Mash","url":"https://stock-news.laohu8.com/highlight/detail?id=2559043967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559043967?lang=en_us&edition=fundamental","pubTime":"2025-08-15 06:30","pubTimestamp":1755210600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nTUA57MVC2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4588","BK4585","BK4139","AKRO"],"gpt_icon":0},{"id":"2559982467","title":"Andrew Cheng, President and CEO, Reports Disposal of Akero Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559982467","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559982467?lang=en_us&edition=fundamental","pubTime":"2025-08-14 06:37","pubTimestamp":1755124658,"startTime":"0","endTime":"0","summary":"Andrew Cheng, President and CEO of Akero Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL9kKncg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4505","BK4588","AKRO"],"gpt_icon":0},{"id":"2559620753","title":"Director Jane Henderson Reports Disposal of Common Shares in Akero Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2559620753","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559620753?lang=en_us&edition=fundamental","pubTime":"2025-08-13 08:33","pubTimestamp":1755045203,"startTime":"0","endTime":"0","summary":"Jane Henderson, a Director of Akero Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL2317Tl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4505","BK4139","AKRO"],"gpt_icon":0},{"id":"2558661836","title":"Akero Therapeutics (AKRO) Receives a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2558661836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558661836?lang=en_us&edition=fundamental","pubTime":"2025-08-11 23:16","pubTimestamp":1754925378,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Edward Nash maintained a Buy rating on Akero Therapeutics today and set a price target of $73.00. The company’s shares op...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/akero-therapeutics-akro-receives-a-buy-from-canaccord-genuity-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/akero-therapeutics-akro-receives-a-buy-from-canaccord-genuity-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4505","AKRO","BK4585"],"gpt_icon":0},{"id":"2558054265","title":"Akero Therapeutics Advances in MASH Treatment Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2558054265","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558054265?lang=en_us&edition=fundamental","pubTime":"2025-08-09 12:17","pubTimestamp":1754713035,"startTime":"0","endTime":"0","summary":"Akero Therapeutics ( ($AKRO) ) has released its Q2 earnings. Here is a breakdown of the information Akero Therapeutics presented to its investors. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/akero-therapeutics-advances-in-mash-treatment-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/akero-therapeutics-advances-in-mash-treatment-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","AKRO","BK4139","BK4588","BK4505"],"gpt_icon":0},{"id":"2558757760","title":"Ritu Baral Recommends Buy Rating for Akero Therapeutics Amid Promising Clinical Trials and Strong Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2558757760","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558757760?lang=en_us&edition=fundamental","pubTime":"2025-08-09 05:35","pubTimestamp":1754688920,"startTime":"0","endTime":"0","summary":"Analyst Ritu Baral of TD Cowen maintained a Buy rating on Akero Therapeutics, retaining the price target of $76.00. Ritu Baral has given her Buy ra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ritu-baral-recommends-buy-rating-for-akero-therapeutics-amid-promising-clinical-trials-and-strong-financial-position-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ritu-baral-recommends-buy-rating-for-akero-therapeutics-amid-promising-clinical-trials-and-strong-financial-position-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKRO"],"gpt_icon":0},{"id":"2557520652","title":"Akero Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2557520652","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557520652?lang=en_us&edition=fundamental","pubTime":"2025-08-08 21:56","pubTimestamp":1754661407,"startTime":"0","endTime":"0","summary":"Akero Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryAkero Therapeutics Inc AKRO.OQ reported a quarterly adjusted loss of 90 cents per share for the quarter ended Ma","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U02B2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKRO"],"gpt_icon":0},{"id":"2557529886","title":"Akero Therapeutics Q2 Net Income USD -70.505 Million Vs. IBES Estimate USD -70.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557529886","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557529886?lang=en_us&edition=fundamental","pubTime":"2025-08-08 19:30","pubTimestamp":1754652609,"startTime":"0","endTime":"0","summary":"Aug 08 (Reuters) - Akero Therapeutics Q2 operating income USD -80.873 million vs. IBES estimate USD -80.9 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 08-AUG-202511:15:45.697 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nRSD16DJpT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4505","BK4588","AKRO"],"gpt_icon":0},{"id":"2557526978","title":"Earnings Flash (AKRO) Akero Therapeutics Posts Q2 Net Loss $0.86 a Share, vs. FactSet Est of $0.96 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2557526978","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557526978?lang=en_us&edition=fundamental","pubTime":"2025-08-08 19:20","pubTimestamp":1754652000,"startTime":"0","endTime":"0","summary":"Earnings Flash (AKRO) Akero Therapeutics Posts Q2 Net Loss $0.86 a Share, vs. FactSet Est of $0.96 Loss","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKRO"],"gpt_icon":0},{"id":"2557541526","title":"Akero Therapeutics Q2 EPS $(0.86) Beats $(0.93) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557541526","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557541526?lang=en_us&edition=fundamental","pubTime":"2025-08-08 19:18","pubTimestamp":1754651882,"startTime":"0","endTime":"0","summary":"Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(0.93) by 7.53 percent. This is a 6.17 percent decrease over losses of $(0.81) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46994508/akero-therapeutics-q2-eps-0-86-beats-0-93-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKRO"],"gpt_icon":0},{"id":"2557526846","title":"Akero Therapeutics Reports Increased Q2 2025 Operating Expenses, No Revenue or Profit Data Provided","url":"https://stock-news.laohu8.com/highlight/detail?id=2557526846","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557526846?lang=en_us&edition=fundamental","pubTime":"2025-08-08 19:15","pubTimestamp":1754651717,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akero Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on August 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nNDL1YTP0h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKRO","NDAQ"],"gpt_icon":0},{"id":"2557526808","title":"Akero Therapeutics Q2 Basic EPS USD -0.86","url":"https://stock-news.laohu8.com/highlight/detail?id=2557526808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557526808?lang=en_us&edition=fundamental","pubTime":"2025-08-08 19:15","pubTimestamp":1754651700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nPLXB236FB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","AKRO","BK4139","BK4588","BK4505"],"gpt_icon":0},{"id":"2557250275","title":"Akero Therapeutics Q2 Net Income USD -70.505 Million VS. Ibes Estimate USD -70.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557250275","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557250275?lang=en_us&edition=fundamental","pubTime":"2025-08-08 19:15","pubTimestamp":1754651700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nPLXB236FB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKRO","BK4139","BK4588","BK4505","BK4585"],"gpt_icon":0},{"id":"2557566692","title":"Chief Scientific Officer Timothy Rolph Reports Disposal of Akero Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2557566692","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557566692?lang=en_us&edition=fundamental","pubTime":"2025-08-07 21:00","pubTimestamp":1754571639,"startTime":"0","endTime":"0","summary":"Timothy Rolph, Chief Scientific Officer, reported a disposal of common shares of Akero Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 07, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nNDLgkjTC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4585","BK4505","AKRO"],"gpt_icon":0},{"id":"2556800557","title":"Akero Therapeutics initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2556800557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556800557?lang=en_us&edition=fundamental","pubTime":"2025-08-04 17:46","pubTimestamp":1754300769,"startTime":"0","endTime":"0","summary":"TD Cowen initiated coverage of Akero Therapeutics (AKRO) with a Buy rating and $76 price target The firm believes the company’s efruxifermin, an FG...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/akero-therapeutics-initiated-with-a-buy-at-td-cowen-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/akero-therapeutics-initiated-with-a-buy-at-td-cowen-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","BK4566","BK4207","AKRO","BK4585","COWN","BK4139","BK4588","TD","BK4505"],"gpt_icon":0},{"id":"2556810133","title":"Akero Therapeutics Advances Efruxifermin Study for NASH Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2556810133","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556810133?lang=en_us&edition=fundamental","pubTime":"2025-08-02 00:33","pubTimestamp":1754066030,"startTime":"0","endTime":"0","summary":"Akero Therapeutics (($AKRO)) announced an update on their ongoing clinical study. Akero Therapeutics is conducting a Phase 3 study titled ‘A Study ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/akero-therapeutics-advances-efruxifermin-study-for-nash-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/akero-therapeutics-advances-efruxifermin-study-for-nash-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4505","BK4585","AKRO"],"gpt_icon":0},{"id":"2555023074","title":"Akero Therapeutics Advances Phase 3 Study on Efruxifermin for NASH/MASH Cirrhosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2555023074","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555023074?lang=en_us&edition=fundamental","pubTime":"2025-07-31 00:10","pubTimestamp":1753891806,"startTime":"0","endTime":"0","summary":"Akero Therapeutics (($AKRO)) announced an update on their ongoing clinical study. Akero Therapeutics is conducting a Phase 3 clinical study titled ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/akero-therapeutics-advances-phase-3-study-on-efruxifermin-for-nash-mash-cirrhosis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/akero-therapeutics-advances-phase-3-study-on-efruxifermin-for-nash-mash-cirrhosis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4505","BK4588","AKRO"],"gpt_icon":0},{"id":"2554753051","title":"BB Biotech AG Reports Q2 2025 Net Loss of CHF 100 Million; USD Share Price Up 10.2%, Currency Drag Impacts CHF Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2554753051","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554753051?lang=en_us&edition=fundamental","pubTime":"2025-07-25 13:00","pubTimestamp":1753419618,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BB Biotech AG published the original content used to generate this news brief on July 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL9D9cFs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRRK","BK4539","EWTX","IMCR","BK4505","AKRO","BK4585","LU0053671581.USD","BK4588","BK4007","BK4139","BPMC","ESPR"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":74,"code":"91000000","status":"200"}]}}